Does joint effusion influence the clinical response to a single Hylan GF-20 injection for hip osteoarthritis?

Joint Bone Spine

Volumn 75, Issue 2, 2008, Pages 182-188

  Rennesson Rey, Bénédicte ^a   Rat, Anne Christine ^c   Chary Valckenaere, Isabelle ^b   Bettembourg Brault, Isabelle ^a   Juge, Nadine ^c   Dintinger, Hervé ^a   Pourel, Jacques ^b   Loeuille, Damien ^b  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b UNIVERSITÉ DE LORRAINE   (France)

^c INSERM   (France)

Author keywords

Hip osteoarthritis; Hylan GF 20; Joint effusion; Ultrasonography

Indexed keywords

ANALGESIC AGENT; HYALURONIC ACID; HYLAN; HYLAN GF 20; NONSTEROID ANTIINFLAMMATORY AGENT; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; ECHOGRAPHY; FEMALE; HIP OSTEOARTHRITIS; HUMAN; JOINT EFFUSION; LEQUESNE ALGOFUNCTIONAL INDEX; MAJOR CLINICAL STUDY; MALE; MAXIMUM ALLOWABLE CONCENTRATION; PAIN ASSESSMENT; POPULATION RESEARCH; PROSPECTIVE STUDY; SINGLE DRUG DOSE; STATISTICAL SIGNIFICANCE; TREATMENT RESPONSE; VISUAL ANALOG SCALE; WOMAC;

ADULT; AGED; BIOCOMPATIBLE MATERIALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYALURONIC ACID; INJECTIONS, INTRA-ARTICULAR; MALE; MIDDLE AGED; OSTEOARTHRITIS, HIP; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SYNOVIAL FLUID; TREATMENT OUTCOME;

EID: 40949099581     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2007.05.017     Document Type: Article

References (35)

1. Pelletier J.P., and Martel-Pelletier J. The pathophysiology of osteoarthritis and the implication of the use of hyaluronan and hylan as therapeutic agents in viscosupplementation. J Rheumatol Suppl 39 (1993) 19-24
2. Dahl L.B., Dahl I.M., Engstrom-Laurent A., and Granath K. Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies. Ann Rheum Dis 44 (1985) 817-822
3. Lo G.H., LaValley M., McAlindon T., and Felson D.T. Intra-articular hyaluronic acid in treatment of knee osteoarthritis: a meta-analysis. JAMA 290 (2003) 3115-3121
4. Wang C.T., Lin J., Chang C.J., Lin Y.T., and Hou S.M. Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. A meta-analysis of randomized controlled trials. J Bone Joint Surg Am 86-A (2004) 538-545
5. Bellamy N., Campbell J., Robinson V., Gee T., Bourne R., and Wells G. Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev (2005) CD005328
6. Arrich J., Piribauer F., Mad P., Schmid D., Klaushofer K., and Mullner M. Intra-articular hyaluronic acid for the treatment of osteoarthritis of the knee: systematic review and meta-analysis. CMAJ 172 (2005) 1039-1043
7. Jordan K.M., Arden N.K., Doherty M., Bannwarth B., Bijlsma J.W., and Dieppe P. Standing Committee for International Clinical Studies Including Therapeutic Trials ESCISIT. EULAR Recommendations 2003. An evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 62 (2003) 1145-1155
8. Fraser J.R., Kimpton W.G., Pierscionek B.K., and Cahill R.N. The kinetics of hyaluronan in normal and acutely inflamed synovial joints: observations with experimental arthritis in sheep. Semin Arthritis Rheum 22 (1993) 9-17
9. Julovi S.M., Yasuda T., Shimizu M., Hiramitsu T., and Nakamura T. Inhibition of interleukin-1 beta - stimulated production of metalloproteinases by hyaluronan via CD 44 in human articular cartilage. Arthritis Rheum 50 (2004) 516-525
10. Yasui T., Akatsuka M., Tobetto K., Hayaishi M., and Ando T. The effect of hyluronan on interleukin-1 alpha induced prostaglandin E2 production by human osteoarthritic synovial fibroblasts. Agents Action 37 (1992) 155-156
11. Comer J.S., Kincaid S.A., Baird A.N., Kammermann J.R., Hanson Jr. R.R., and Ogawa Y. Immunolocalisation of stromelysin, tumor necrosis alpha, and TNF receptors in atrophied canine articular cartilage treated with hyaluronic acid and transforming growth factor beta. Am J Vet Res 57 (1996) 1488-1496
12. Sato H., Takahashi T., Ide H., Fukushima T., Tabata M., Sekine F., et al. Antioxidant activity of synovial fluid, hyaluronic acid and two subcomponents of hyaluronic acid. Arthritis Rheum 31 (1988) 63-71
13. Brocq O., Tran G., Breuil V., Grisot C., Flory P., and Euller-Ziegler L. Hip osteoarthritis: short term efficacy and safety of viscosupplementation by hylan GF-20. An open - label study in 22 patients. Joint Bone Spine 69 (2002) 388-391
14. Bragantini A., and Molinaroli F. A pilot clinical evaluation of the treatment of hip osteoarthritis with hyaluronic acid. Curr Ther Res 55 3 (1994) 319-330
15. Conrozier T., Bertin P., Mathieu P., Charlot J., Bailleul F., Treves R., et al. Intra articular injections of hylan GF 20 in patients with symptomatic hip osteoarthritis: an open label, multicentre, pilot study. Clin Exp Rheum 21 (2003) 605-610
16. Vad V.B., Sakalkale D., Sculco T.P., and Wickiewicz T.L. Role of hylan G-F 20 in treatment of osteoarthritis of the hip joint. Arch Phys Med Rehabil 84 (2003) 1224-1226
17. Caglar-Yagci H., Unsal S., Yagci I., Dulgeroglu D., and Ozel S. Safety and efficacy of ultrasound-guided intra-articular hylan G-F 20 injection in osteoarthritis of the hip: a pilot study. Rheumatol Int 25 (2005) 341-344
18. Migliore A., Martin L.S., Alimonti A., Valente C., and Tormenta S. Efficacy and safety of viscosupplementation by ultrasound-guided intra-articular injection in osteoarthritis of the hip. Osteoarthritis Cartilage 11 (2003) 305-306
19. Berg P., and Olsson U. Intra-articular injection of non-animal stabilised hyaluronic acid (NASHA) for osteoarthritis of the hip: a pilot study. Clin Exp Rheumatol 22 (2004) 300-306
20. Qvistgaard E., Christensen R., Torp-Pedersen S., and Bliddal H. Intra-articular treatment of hip osteoarthritis: a randomized trial of hyaluronic acid, corticosteroid, and isotonic saline. Osteoarthritis Cartilage 14 (2006) 163-170
21. Altman R., Alarcon G., Appelrouth D., Bloch D., Borenstein D., Brandt K., et al. American College of Rheumatology. Criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum 34 (1991) 505-514
22. Lequesne M.G., Mery C., Samson M., and Gerard P. Indexes of severity for osteoarthritis of the hip and knee. Validation-value in comparison with other assessment tests. Scand J Rheumatol 65 (1987) 85-89
23. Bellamy N., Buchanan W.W., Goldsmith C.H., Campbell J., and Stitt L.W. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 15 (1988) 1833-1840
24. Perneger T.V., Leplege A., Etter J.F., and Rougemont A. Validation of a French-language version of the MOS 36-Item Short Form Health Survey (SF-36) in young healthy adults. J Clin Epidemiol 48 (1995) 1051-1060
25. Rat A.C., Coste J., Pouchot J., Baumann M., Spitz E., Retel-Rude N., et al. OAKHQOL: a new instrument to measure quality of life in knee and hip osteoarthritis. J Clin Epidemiol 58 (2005) 47-55
26. Kellgren J.K., and Lawrence J.S. Radiological assessment of osteoarthritis. Ann Rheum Dis 16 (1957) 494-502
27. Schmidt W.A., Schmidt H., Schicke B., and Gromnica-Ihle E. Standard reference values for musculoskeletal ultrasonography. Ann Rheum Dis 63 (2004) 988-994
28. Walther M., Harms H., Krenn V., Radke S., Kirschner S., and Gohlke F. Synovial tissue of the hip at power Doppler US: correlation between vascularity and power Doppler US signal. Radiology 225 (2002) 225-231
29. Pham T., van der Heijde D., Altman R.D., Anderson J.J., Bellamy N., Hochberg M., et al. OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. Osteoarthritis Cartilage 12 (2004) 389-399
30. Tubach F., Ravaud P., Baron G., Falissard B., Logeart I., Bellamy N., et al. Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state. Ann Rheum Dis 64 (2005) 34-37
31. Boutry N., Paul C., Leroy X., Fredoux D., Migaud H., and Cotten A. Rapidly destructive osteoarthritis of the hip: MR imaging findings. Am J Roentgenol 179 (2002) 657-663
32. Wilson D.J., Green D.J., and MacLarnon J.C. Arthrosonography of the painful hip. Clin Radiol 35 (1984) 17-19
33. Rosenborg M., Nybonde T., and Mortensson W. Ultraljudsundersökning av höftleden utmärkt complement vid misstanke om koxit. Läkartidningen 82 (1985) 184-185
34. Rydholm U., Wingstrand H., Egund N., Elborg R., Forsberg L., and Lidgren L. Sonography, arthroscopy and intracapsular pressure in juvenile chronic arthritis of the hip. Acta Orthop Scand 57 (1986) 295-298
35. Dore D.D., Tandon S., and Taber J.K. Treatment of hip osteoarthritis pain with intra articular Hyalgan injections. Arthritis Rheum (2004) Sup ACR: Abstract 1146